Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-pwh-lee-quo-wei-cardiovascular-intervention-centre-officially-opens-equipped-with-cutting-edge-technology-to-serve-the-territory
https://www.med.cuhk.edu.hk/press-releases/cuhk-pwh-lee-quo-wei-cardiovascular-intervention-centre-officially-opens-equipped-with-cutting-edge-technology-to-serve-the-territory

CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre Officially Opens Equipped with Cutting Edge Technology to Serve the Territory

The opening ceremony of the CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre was held today (2 April). Officiating guests included Dr. the Honorable Lee Quo-wei, Chairman of the Wei Lun Foundation Limited and Former Chairman and Life Member of the Council, The Chinese University of Hong Kong (CUHK) and Mrs. Lee; Mr. Anthony Wu, Chairman of the Hospital Authority; Dr. Vincent Cheng, Chairman of the Council, CUHK; Prof. Joseph Sung, Vice-Chancellor and President, CUHK; Mr. Edward Ho, Chairman of the Hospital Governing Committee, Prince of Wales Hospital (PWH); Dr. Fung Hong, Cluster Chief Executive, New Territories East Cluster; Prof. Fok Tai-fai, Dean, Faculty of Medicine, CUHK; and Prof. Yu Cheuk-man, Chairman of the Department of Medicine and Therapeutics, Faculty of Medicine, CUHK and Director of the Lee Quo Wei Cardiovascular Intervention Centre.

 

(From left) Prof. Yu Cheuk-man, Chairman of the Department of Medicine and Therapeutics, Faculty of Medicine, CUHK, and Director of the Lee Quo Wei Cardiovascular Intervention Centre; Dr. Fung Hong, Cluster Chief Executive, New Territories East Cluster; Prof. Joseph Sung, Vice-Chancellor and President, CUHK; Dr. Vincent Cheng, Chairman of the Council, CUHK; Dr. the Honorable Lee Quo-wei, Chairman of the Wei Lun Foundation Limited and Former Chairman and Life Member of the Council, CUHK, and Mrs. Lee; Mr. Anthony Wu, Chairman of the Hospital Authority; Mr. Edward Ho, Chairman of the Hospital Governing Committee, Prince of Wales Hospital; and Prof. Fok Tai-fai, Dean, Faculty of Medicine, CUHK, officiate at the Opening Ceremony of the CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre

(From left) Prof. Yu Cheuk-man, Chairman of the Department of Medicine and Therapeutics, Faculty of Medicine, CUHK, and Director of the Lee Quo Wei Cardiovascular Intervention Centre; Dr. Fung Hong, Cluster Chief Executive, New Territories East Cluster; Prof. Joseph Sung, Vice-Chancellor and President, CUHK; Dr. Vincent Cheng, Chairman of the Council, CUHK; Dr. the Honorable Lee Quo-wei, Chairman of the Wei Lun Foundation Limited and Former Chairman and Life Member of the Council, CUHK, and Mrs. Lee; Mr. Anthony Wu, Chairman of the Hospital Authority; Mr. Edward Ho, Chairman of the Hospital Governing Committee, Prince of Wales Hospital; and Prof. Fok Tai-fai, Dean, Faculty of Medicine, CUHK, officiate at the Opening Ceremony of the CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre.

The Centre was established in 2010 with the generous donation from Dr. Lee Quo-wei, his family and the Wei Lun Foundation Limited. Located on the second floor of the Main Clinical Block and Trauma Centre of the PWH, the 3,000-square-feet Centre is equipped with advanced imaging and invasive equipment to provide unique and comprehensive diagnosis and treatment for cardiovascular diseases (including coronary heart disease, cardiac arrhythmia and heart failure), serving a population of 1.3 million in the New Territories East Cluster. It also serves as a referral centre for cardiovascular diseases for the rest of Hong Kong.

Prof. Joseph Sung, Vice-Chancellor and President, CUHK, expressed his gratitude to the Lee family and the Wei Lun Foundation Limited, 'The University is indebted to the Lee family and the Foundation for their generous and continued support. They have been staunch supporters of the University, helping to enhance our strength and competitiveness in teaching, research and public service. Their far-sighted vision not only allowed the Centre to come into existence, but has also benefited patients in need so that they can be diagnosed and treated promptly and properly with cutting edge technologies.

 

Mr. Anthony Wu, Chairman of the Hospital Authority (2nd right); Dr. Vincent Cheng, Chairman of the Council, CUHK (1st right) and Prof. Joseph Sung, Vice-Chancellor and President, CUHK (1st left) jointly present a calligraphy written by Professor Sung as a souvenir to Mrs. Lee (2nd left)

Mr. Anthony Wu, Chairman of the Hospital Authority (2nd right); Dr. Vincent Cheng, Chairman of the Council, CUHK (1st right) and Prof. Joseph Sung, Vice-Chancellor and President, CUHK (1st left) jointly present a calligraphy written by Professor Sung as a souvenir to Mrs. Lee (2nd left).

Mr. Anthony Wu, Chairman of the Hospital Authority said, 'Despite the development of new drugs and technologies, cardiovascular diseases remain the second leading cause of death in Hong Kong, taking away more than 5,000 lives each year. The fight against cardiovascular diseases entails high costs, advanced technology and meticulous skills. Despite these great challenges, the Hospital Authority is firmly committed to providing quality healthcare to patients suffering from cardiovascular diseases.'

 

The CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre, equipped with state-of-the-art facilities and cutting edge technology, performs more than 2,500 invasive cardiovascular procedures every year to serve patients suffering from cardiovascular diseases in the territory

The CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre, equipped with state-of-the-art facilities and cutting edge technology, performs more than 2,500 invasive cardiovascular procedures every year to serve patients suffering from cardiovascular diseases in the territory.

Prof. Yu Cheuk-man, Director of the Centre, said that the Centre was the only one in Hong Kong performing renal sympathetic denervation in public setting, left atrial appendage (LAA) occluder and cardiac contractility modulation (CCM) implantation. It runs the largest percutaneous coronary intervention (PCI) and electrophysiology (EP) service in Hong Kong, including the largest volume of complex radiofrequency ablation and chronic total occlusion PCI, in particular retrograde approach recanalization. Integral to the Centre is a multi-disciplinary team which enables it to run a regular and the largest peripheral vascular intervention service. The PWH is one of the two public hospitals in Hong Kong performing transcatheter aortic-valve implantation (TAVI). Currently, the Centre performs more than 2,500 invasive cardiovascular procedures every year using the latest interventional technologies.

Looking forward, the Centre pledges to provide a wide range of diagnostic and therapeutic procedures with cutting edge technologies and dedicated cardiovascular experts.

 

Supported by Dr. Lee Quo-wei, his family and the Wei Lun Foundation Limited, the 3,000-square-feet CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre located on the second floor of the Main Clinical Block and Trauma Centre of the PWH officially opens as a referral centre for cardiovascular diseases for the rest of Hong Kong.

Supported by Dr. Lee Quo-wei, his family and the Wei Lun Foundation Limited, the 3,000-square-feet CUHK-PWH Lee Quo Wei Cardiovascular Intervention Centre located on the second floor of the Main Clinical Block and Trauma Centre of the PWH officially opens as a referral centre for cardiovascular diseases for the rest of Hong Kong.

More Press Releases

CUHK leads multi-centre Asian study showing that an early screen-and-prevent strategy for preterm preeclampsia is effective at lowering risk of complications for high-risk women by 41%  Pilot service at Prince of Wales Hospital showed promising outcome

CUHK leads multi-centre Asian study showing that an early screen-and-prevent strategy for preterm preeclampsia is effective at lowering risk of complications for high-risk women by 41% Pilot service at Prince of Wales Hospital showed promising outcome

Research
CUHK-PWH team achieves breakthrough in using one single tricuspid catheter to repair both mitral and tricuspid valves for treating severe regurgitation

CUHK-PWH team achieves breakthrough in using one single tricuspid catheter to repair both mitral and tricuspid valves for treating severe regurgitation

Research
A CU-led international study identifies metabolomic markers for diabetic kidney disease and cardiovascular disease in patients with type 2 diabetes

A CU-led international study identifies metabolomic markers for diabetic kidney disease and cardiovascular disease in patients with type 2 diabetes

Research
A major international study identifies biomarkers that enhance prediction accuracy of cardiovascular diseases in people with diabetes and have potential to change clinical practice

A major international study identifies biomarkers that enhance prediction accuracy of cardiovascular diseases in people with diabetes and have potential to change clinical practice

Research
CUHK-PWH research confirms Paxlovid can benefit patients with severe kidney disease

CUHK-PWH research confirms Paxlovid can benefit patients with severe kidney disease

Research
CUHK study shows control of lipid levels is crucial  to prevent cardiac events after coronary artery bypass graft

CUHK study shows control of lipid levels is crucial to prevent cardiac events after coronary artery bypass graft

Research
CU Medicine Researchers Discover Shortened DNA Telomere Length as a Useful Biomarker to Identify Patients with Diabetes at High Risk of Cardiovascular Disease

CU Medicine Researchers Discover Shortened DNA Telomere Length as a Useful Biomarker to Identify Patients with Diabetes at High Risk of Cardiovascular Disease

Research
CUHK Study Proves Achieving Sustained Minimal Disease Activity Lowers the Risk of Cardiovascular Diseases in Psoriatic Arthritis Patients

CUHK Study Proves Achieving Sustained Minimal Disease Activity Lowers the Risk of Cardiovascular Diseases in Psoriatic Arthritis Patients

Research
CUHK Study Sees Shorter Sleep Put Adolescents at Risk of Future Cardiovascular Diseases

CUHK Study Sees Shorter Sleep Put Adolescents at Risk of Future Cardiovascular Diseases

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK Pioneers Innovative Bioimpedance Spectroscopy for Early Assessment of Cardiovascular Risks of End Stage Renal Failure Patients

CUHK Pioneers Innovative Bioimpedance Spectroscopy for Early Assessment of Cardiovascular Risks of End Stage Renal Failure Patients

Research
CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.